Holdings PLC () chief executive Dr Adam Hill speaks to Proactive London as the firm announced the positive results of a large-scale lung cancer study.
The company’s EarlyCDT-Lung test was used alongside x-rays and CT scans to check for the disease.
A total of 12,210 people in Scotland were monitored for two years as part of the Early Cancer Detection Test in what is believed to be the largest randomised controlled assessment of its kind.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Oncimmune named herein, including the promotion by the Company of Oncimmune in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE